ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.716,42
-0,12%
S&P 500
5.245,03
0,45%
Dow Jones
39.558,54
0,32%
Euro vs US Dollar
1,08213
0,25%
Bitcoin
61.557,06
-2,14%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ZimVie Inc (ZIMV)

  7. ZimVie Inc (ZIMV) News

ZIMV ZimVie Inc

16,83
0,01 (0,06%)
Zuletzt aktualisiert: 21:21:51
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ZimVie Inc ZIMV NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,01 0,06% 16,83 21:21:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
17,06 16,73 17,17 16,82
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202422:11EDGAR2Form 8-K - Current report
08.5.202422:05GLOBEZimVie Reports First Quarter 2024 Financial Results
24.4.202422:05GLOBEZimVie to Report First Quarter Financial Results on May 8,..
01.4.202414:00GLOBEZimVie Announces Closing of Sale of Spine Business
27.3.202413:00GLOBEZimVie to Participate in the 23rd Annual Needham Virtual..
11.3.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202402:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28.2.202422:10EDGAR2Form 8-K - Current report
28.2.202422:05GLOBEZimVie Reports Fourth Quarter and Full Year 2023 Financial..
27.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202423:00GLOBEZimVie to Report Fourth Quarter and Full-Year 2023 Financial..
14.2.202421:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202421:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.2.202422:05GLOBEZimVie Announces Launch of Next-Generation TSX® Implant in..
02.1.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:15EDGAR2Form 8-K - Current report
18.12.202314:20EDGAR2Form 8-K - Current report
18.12.202314:00GLOBEZimVie Announces Definitive Agreement to Sell Spine Business..
12.12.202314:00GLOBEZimVie Announces Compatibility Between its Vital™ Spinal..
01.11.202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202321:11EDGAR2Form 8-K - Current report
01.11.202321:05GLOBEZimVie Reports Third Quarter 2023 Financial Results and..
31.10.202313:00GLOBEZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C®..
24.10.202314:00GLOBEZimVie Announces Over 2,000 Children Have Received The..
17.10.202314:30GLOBEZimVie Announces the Launch of Azure™ Multi-Platform Product..
11.10.202322:05GLOBEZimVie to Report Third Quarter 2023 Financial Results on..
10.10.202314:30GLOBEZimVie Announces the Recent Launch of Biotivity™ A/C Plus..
03.10.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202314:00GLOBEZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
17.8.202314:00GLOBEZimVie Expands Development Cooperation Agreement with..
10.8.202314:00GLOBEZimVie Announces FDA Approval for New Mobi-C® Implant
03.8.202322:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
02.8.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202322:10EDGAR2Form 8-K - Current report
02.8.202322:05GLOBEZimVie Reports Second Quarter 2023 Financial Results and..
12.7.202322:05GLOBEZimVie to Report Second Quarter 2023 Financial Results on..
05.7.202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
ZIMV
ZimVie
LSE
DFCH
Distribution Finance Cap...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten